Cite

HARVARD Citation

    Lair-Mehiri, L. et al. (2020). Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis. Digestive and liver disease. 52 (3), pp. 268-273. [Online]. 
  
Back to record